In SUSTAIN-7, a study comparing semaglutide to dulaglutide in patients with inadequately controlled T2DM, a greater reduction in body weight was observed with 0.5 mg semaglutide (4.6 kg, standard error [SE] 0.28) compared with 0.75 mg dulaglutide (2.3 kg, SE 0.27) (estimated treatment difference [ETD] 2.26 kg, 95% CI 3.02 to 1.51
Exenatide, when combined with metformin, has been shown to significantly suppress the proliferation of breast cancer cells [104]
Sodium-glucose transport protein 2 (SGLT2) inhibitors, StatPearls (2023) Genital infections with sodium glucose cotransporter-2 inhibitors: Occurrence and management in patients with Type 2 diabetes mellitus, Indian Journal of Endocrinology and Metabolism (2018) Preventing candidiasis, Centers for Disease Control and Prevention (2024) Jardiance, DailyMed (2024) Ozempic, DailyMed (2023) Glucagon-like peptide-1 receptor agonists, StatPearls (2024) Patient education: Vaginal yeast infection (Beyond the Basics), UpToDate (2023) Medically accurate: SingleCares Medical Review Board analyzes all of our content to confirm its in line with current medical advice
Eli Lilly and Company
Hurst, K
